CK20

CK20 is an intermediate filament with a selective expression pattern in different carcinomas, which when combined with CD7 is useful in the work up of carcinomas of unknown primary origin.
 
Common expression patterns in carcinoma (Dennis, JL, et al).
Tumor
(%)
Breast
<10%
Colon
>80%
Lung
<10%
Ovary
<10%
Pancreas
35-50%
Stomach
30-50%
Prostate
<10%
 
Moll, RT, et al.  Cytokeratin expression in various tumors.
Tumor
CK8/CK18
CK19
CK7
CK20
CK5
Hepatocellular Ca.
+
+/-
+/-
+/-
=
Colorectal ACA
+
+
+/-
+
=
Stomach ACA
+
+
+/-
+/-
=
Pancreas Ductal ACA
+
+
+
+/-
+/-
Lung ACA
+
+
+
=
=
Breast Inv. Ductal
+
+
+
=
+/-
Endometrium ACA
+
+
+
=
+/-
Ovary ACA 
+
+
+
=
=
RCC, Clear Cell Type
+
+/-
=
=
=
RCC, Papillary Type
+
+
+
=
=
RCC, Chromophobe
+
+/-
+
=
=
Mesothelioma
+
+
+/-
=
+
Lung, Small Cell Ca.
+
+/-
=
=
=
Merkel Cell Ca.
+
+
=
+
=
Urothelial Carcinoma
+
+
+
+/-
+/-
Squamous Cell Ca.
+/-
+/-
=
=
+
Key:  “+/-“, focal staining in some cases. “=“, negative, “+”, positive.
Photomicrographs
CK20 - Lung Adenocarcinoma
CK20 expression (or lack thereof) in lung adneocarcinoma (CK7+/CK20-).
CK20 - Colon Adenocarcinoma
CK20 expression in colon adenocarcinoma.
CK20 - Colon Adenocarcinoma
CK20 expression in underlying colon adenocarcinoma, and normal expression in overlying benign mucosa (increased expression as it becomes more superficial).
References
Hadi, AIMM Annual Meeting, “The Thirty Most Important Antibodies”, presentation, 2011.
 
Dennis, J. L., Hvidsten, T. R., Wit, E. C., Komorowski, J., Bell, A. K., Downie, I., et al. (2005). Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 11(10), 3766–3772. doi:10.1158/1078-0432.CCR-04-2236  
 
Moll, R., Divo, M., & Langbein, L. (2008). The human keratins: biology and pathology. Histochemistry and Cell Biology, 129(6), 705–733. doi:10.1007/s00418-008-0435-6